Health News Archive - April 28, 2009
S.MAMEDE DO CORONADO, Portugal and LONDON, April 28 /PRNewswire/ -- - New Option for Treatment of Epilepsy Patients With Partial Onset Seizures Bial-Portela & CA, S.A., (S.
Pomegranate juice may slow the progress of recurring prostate cancer, U.S. and Israeli researchers say. The two-stage clinical trial tracked 48 men over six years who had had rising prostate specific antigen scores after surgery or radiation.
Pathogen Identification Results in 90 Minutes Direct from Positive Blood Cultures Faster Results to Help Clinicians Improve Antibiotic Selection and Outcomes for Critical Infections WOBURN, Mass.
One dead person every day from anesthesia over medication should be a 'wake up' call, says Dr.
World-Renowned Biomedical Research and Treatment Facility Deploys Isilon Scale-out NAS to Power DNA Sequencing Workflow, Accelerating Cancer, Diabetes, and HIV/AIDS Research SEATTLE, April 28 /PRNewswire-FirstCall/ -- Isilon(R) Systems (Nasdaq: ISLN), the proven leader in scale-out NAS, today announced that City of Hope, a National Cancer Institute-designated Comprehensive Cancer Center, has deployed Isilon IQ to accelerate its next-generation DNA sequencing operations and speed time-to-results for groundbreaking research for cancer, diabetes, and HIV/AIDS.
- Reports earnings per share from continuing operations of $1.06, or $1.18 after excluding specified item - Reaffirms guidance for full fiscal year 2009 earnings per share from continuing operations, excluding specified item FRANKLIN LAKES, N.J., April 28 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today reported quarterly revenues of $1.741 billion for the second fiscal quarter ended March 31, 2009, representing a decrease of 0.4 percent from the prior year period.
National healthcare recruiting firm reports survey showing increased use of Facebook and social networks by doctors and nurses. ALPHARETTA, Ga., April 28 /PRNewswire/ -- Locum Leaders (http://www.locumleaders.com), a leading recruiting firm specializing in physician and CRNA temporary staffing known as locum tenens, today announced the launch of a Locum Link, an innovative social media initiative for healthcare professionals. Locum Link features career and lifestyle blogs, links to Facebook and other popular social networks, and medical education offered in partnership with a leading online community for physicians. The Locum Link portal offers a new twist on traditional medical recruiting and reflects a growing interest among healthcare providers in social media.
FDA confirms durable pain palliation as an acceptable primary endpoint for a regulatory submission in support of market approval BOTHELL, WA, April 28 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc.
OSLO, Norway, April 28 /PRNewswire/ -- Affitech AS, the human antibody therapeutics company, announced today that preclinical data on two fully human anti-PS (phosphatidylserine) antibodies were presented by its collaboration partner Peregrine Pharmaceuticals at the 100th Annual Meeting of the American Association for Cancer Research (AACR) 2009 held during April 18 - 22, 2009 in Denver, CO.
Conference Call and Webcast at 11:00 a.m. Eastern Time THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc.
- The ragged surface of a lava-flow.